Rita H Shah1, Hope Northrup2, James E Hixson3, Alanna C Morrison3, Kit Sing Au4. 1. Division of Neonatology, Department of Pediatrics, The University of Texas Health Science Center at Houston - McGovern Medical School, Houston, Texas. 2. Division of Medical Genetics, Department of Pediatrics, The University of Texas Health Science Center at Houston - McGovern Medical School, Houston, Texas. 3. Department of Epidemiology, Human Genetics, and Environmental Sciences, The University of Texas Health Science Center at Houston - School of Public Health, Houston, Texas. 4. Division of Medical Genetics, Department of Pediatrics, The University of Texas Health Science Center at Houston - McGovern Medical School, Houston, Texas. Kit-Sing.Au@uth.tmc.edu.
Abstract
BACKGROUND: Neural tube defects (NTDs) are one of the most common congenital birth defects, with myelomeningocele (MM) being the most severe form compatible with life. Recent studies show a link between mitochondrial folate one carbon metabolism and NTDs by means of the glycine cleavage system (GCS). We hypothesize that single nucleotide polymorphisms and novel variants in the coding regions of the GCS genes increase the risk for MM. METHODS: DNA was obtained from 96 subjects with MM born before the United States mandated folic acid fortification of grains in 1998. Primers were designed for polymerase chain reaction amplification and sequencing of all exons in the AMT gene, one of four genes in the GCS, followed by identification of single nucleotide polymorphisms and novel variants. An additional 252 MM subjects underwent whole exome sequencing to examine all four GCS genes (aminomethyltransferase, glycine dehydrogenase, glycine cleavage system protein-H, and dihydrolipoamide dehydrogenase). RESULTS: We identified six novel, heterozygous variants in the AMT gene with three predicted to be deleterious to AMT function (p.Val7Leu, p.Pro251Arg, and p.Val380Met). Five extremely rare, known heterozygous variants were found in the AMT gene and one in the GLDC gene. No novel variants in the exons of the other two GCS genes (DLD and GCSH) were identified. CONCLUSION: We identified novel and rare, known variants in two of the four GCS genes that may contribute to the development of MM. Consistent with previous findings, the current study provides additional support that genetic variations in GCS genes contribute to the risk of NTDs. Birth Defects Research (Part A) 106:847-853, 2016.
BACKGROUND:Neural tube defects (NTDs) are one of the most common congenital birth defects, with myelomeningocele (MM) being the most severe form compatible with life. Recent studies show a link between mitochondrial folate onecarbon metabolism and NTDs by means of the glycine cleavage system (GCS). We hypothesize that single nucleotide polymorphisms and novel variants in the coding regions of the GCS genes increase the risk for MM. METHODS: DNA was obtained from 96 subjects with MM born before the United States mandated folic acid fortification of grains in 1998. Primers were designed for polymerase chain reaction amplification and sequencing of all exons in the AMT gene, one of four genes in the GCS, followed by identification of single nucleotide polymorphisms and novel variants. An additional 252 MM subjects underwent whole exome sequencing to examine all four GCS genes (aminomethyltransferase, glycine dehydrogenase, glycine cleavage system protein-H, and dihydrolipoamide dehydrogenase). RESULTS: We identified six novel, heterozygous variants in the AMT gene with three predicted to be deleterious to AMT function (p.Val7Leu, p.Pro251Arg, and p.Val380Met). Five extremely rare, known heterozygous variants were found in the AMT gene and one in the GLDC gene. No novel variants in the exons of the other two GCS genes (DLD and GCSH) were identified. CONCLUSION: We identified novel and rare, known variants in two of the four GCS genes that may contribute to the development of MM. Consistent with previous findings, the current study provides additional support that genetic variations in GCS genes contribute to the risk of NTDs. Birth Defects Research (Part A) 106:847-853, 2016.
Authors: Shigeo Kure; Kumi Kato; Agirios Dinopoulos; Chuck Gail; Ton J DeGrauw; John Christodoulou; Vladimir Bzduch; Rozalia Kalmanchey; Gyorgy Fekete; Alex Trojovsky; Barbara Plecko; Galen Breningstall; Jun Tohyama; Yoko Aoki; Yoichi Matsubara Journal: Hum Mutat Date: 2006-04 Impact factor: 4.878
Authors: Katie A Burren; Dawn Savery; Valentina Massa; Robert M Kok; John M Scott; Henk J Blom; Andrew J Copp; Nicholas D E Greene Journal: Hum Mol Genet Date: 2008-08-26 Impact factor: 6.150
Authors: Philip J Lupo; Mark A Canfield; Claudia Chapa; Wei Lu; A J Agopian; Laura E Mitchell; Gary M Shaw; D Kim Waller; Andrew F Olshan; Richard H Finnell; Huiping Zhu Journal: Am J Epidemiol Date: 2012-11-06 Impact factor: 4.897
Authors: M Ishida; T Cullup; C Boustred; C James; J Docker; C English; N Lench; A J Copp; G E Moore; N D E Greene; P Stanier Journal: Clin Genet Date: 2018-02-11 Impact factor: 4.438
Authors: Kit-Yi Leung; Yun Jin Pai; Qiuying Chen; Chloe Santos; Enrica Calvani; Sonia Sudiwala; Dawn Savery; Markus Ralser; Steven S Gross; Andrew J Copp; Nicholas D E Greene Journal: Cell Rep Date: 2017-11-14 Impact factor: 9.423
Authors: Jessica O'Reilly; Faith Pangilinan; Karsten Hokamp; Per M Ueland; John T Brosnan; Margaret E Brosnan; Lawrence C Brody; Anne M Molloy Journal: Mol Genet Metab Rep Date: 2018-06-11
Authors: Kit-Yi Leung; Sandra C P De Castro; Gabriel L Galea; Andrew J Copp; Nicholas D E Greene Journal: Front Genet Date: 2021-01-25 Impact factor: 4.599
Authors: Chloe Santos; Yun Jin Pai; M Raasib Mahmood; Kit-Yi Leung; Dawn Savery; Simon N Waddington; Andrew J Copp; Nicholas DE Greene Journal: J Clin Invest Date: 2020-03-02 Impact factor: 14.808